These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 12066838)

  • 1. In silico determination of potential antisense targets for human beta-globin variants.
    Arrigo P; Ivaldi G; Cardo PP
    In Silico Biol; 2002; 2(2):143-50. PubMed ID: 12066838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TargetFinder: a software for antisense oligonucleotide target site selection based on MAST and secondary structures of target mRNA.
    Bo X; Wang S
    Bioinformatics; 2005 Apr; 21(8):1401-2. PubMed ID: 15598838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of antisense oligonucleotide binding affinity to a structured RNA target.
    Walton SP; Stephanopoulos GN; Yarmush ML; Roth CM
    Biotechnol Bioeng; 1999 Oct; 65(1):1-9. PubMed ID: 10440665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T-iDT : tool for identification of drug target in bacteria and validation by Mycobacterium tuberculosis.
    Singh NK; Selvam SM; Chakravarthy P
    In Silico Biol; 2006; 6(6):485-93. PubMed ID: 17518759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ASPIC: a web resource for alternative splicing prediction and transcript isoforms characterization.
    Castrignanò T; Rizzi R; Talamo IG; De Meo PD; Anselmo A; Bonizzoni P; Pesole G
    Nucleic Acids Res; 2006 Jul; 34(Web Server issue):W440-3. PubMed ID: 16845044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TF Target Mapper: a BLAST search tool for the identification of Transcription Factor target genes.
    Horsman S; Moorhouse MJ; de Jager VC; van der Spek P; Grosveld F; Strouboulis J; Katsantoni EZ
    BMC Bioinformatics; 2006 Mar; 7():120. PubMed ID: 16524462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of antisense oligonucleotides in the wave of genomic information.
    Baker BF
    Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):397-9. PubMed ID: 11563054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective inhibition of beta-globin RNA transcripts by antisense RNA molecules.
    Pace BS; Qian X; Ofori-Acquah SF
    Cell Mol Biol (Noisy-le-grand); 2004 Feb; 50(1):43-51. PubMed ID: 15040426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of bacterial RNase P RNA as a drug target.
    Willkomm DK; Gruegelsiepe H; Goudinakis O; Kretschmer-Kazemi Far R; Bald R; Erdmann VA; Hartmann RK
    Chembiochem; 2003 Oct; 4(10):1041-8. PubMed ID: 14523922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcript mapping with high-density oligonucleotide tiling arrays.
    Huber W; Toedling J; Steinmetz LM
    Bioinformatics; 2006 Aug; 22(16):1963-70. PubMed ID: 16787969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decoding non-unique oligonucleotide hybridization experiments of targets related by a phylogenetic tree.
    Schliep A; Rahmann S
    Bioinformatics; 2006 Jul; 22(14):e424-30. PubMed ID: 16873503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overview of target validation and the impact of oligonucleotides.
    Jones SW; Lindsay MA
    Curr Opin Mol Ther; 2004 Oct; 6(5):546-50. PubMed ID: 15537056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. mRNA accessible site tagging (MAST): a novel high throughput method for selecting effective antisense oligonucleotides.
    Zhang HY; Mao J; Zhou D; Xu Y; Thonberg H; Liang Z; Wahlestedt C
    Nucleic Acids Res; 2003 Jul; 31(14):e72. PubMed ID: 12853649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antisense oligonucleotides for target validation and gene function determination.
    Taylor MF
    IDrugs; 1999 Aug; 2(8):777-81. PubMed ID: 16127653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AgeWa: an integrated approach for antisense experiment design.
    Arrigo P; Scartezzini P; Romano P
    IEEE Trans Nanobioscience; 2002 Dec; 1(4):167-71. PubMed ID: 16689207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel antisense oligonucleotides targeting TGF-beta inhibit in vivo scarring and improve surgical outcome.
    Cordeiro MF; Mead A; Ali RR; Alexander RA; Murray S; Chen C; York-Defalco C; Dean NM; Schultz GS; Khaw PT
    Gene Ther; 2003 Jan; 10(1):59-71. PubMed ID: 12525838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting the protein SUMO modification sites based on Properties Sequential Forward Selection (PSFS).
    Liu B; Li S; Wang Y; Lu L; Li Y; Cai Y
    Biochem Biophys Res Commun; 2007 Jun; 358(1):136-9. PubMed ID: 17470363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antisense imaging: and miles to go before we sleep?
    Lewis MR; Jia F
    J Cell Biochem; 2003 Oct; 90(3):464-72. PubMed ID: 14523980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tracembler--software for in-silico chromosome walking in unassembled genomes.
    Dong Q; Wilkerson MD; Brendel V
    BMC Bioinformatics; 2007 May; 8():151. PubMed ID: 17490482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FACT--a framework for the functional interpretation of high-throughput experiments.
    Kokocinski F; Delhomme N; Wrobel G; Hummerich L; Toedt G; Lichter P
    BMC Bioinformatics; 2005 Jun; 6():161. PubMed ID: 15985174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.